{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:14:32Z","timestamp":1759936472072},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,22]]},"DOI":"10.7759\/cureus.31808","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T06:04:01Z","timestamp":1669183441000},"source":"Crossref","is-referenced-by-count":3,"title":["Immunoglobulin-Induced Aseptic Meningitis in Juvenile Dermatomyositis: A Case Report"],"prefix":"10.7759","author":[{"given":"Oi Man","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chon In","family":"Kuok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwai Yu Winnie","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoi Man Roanna","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12349","article-title":"Drug-induced aseptic meningitis: a mini-review","volume":"32","author":"Yelehe-Okouma M","year":"2018","unstructured":"Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P. Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol. 2018, 32:252-60. 10.1111\/fcp.12349","journal-title":"Fundam Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Bellutti Enders F","year":"2017","unstructured":"Bellutti Enders F, Bader-Meunier B, Baildam E, et al.. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017, 76:329-40. 10.1136\/annrheumdis-2016-209247","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160688","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash","volume":"44","author":"Huber AM","year":"2017","unstructured":"Huber AM, Kim S, Reed AM, et al.. Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash. J Rheumatol. 2017, 44:110-6. 10.3899\/jrheum.160688","journal-title":"J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference","volume":"64","author":"Huber AM","year":"2012","unstructured":"Huber AM, Robinson AB, Reed AM, et al.. Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken). 2012, 64:546-53. 10.1002\/acr.20695","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.153718","article-title":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis","volume":"70","author":"Lam CG","year":"2011","unstructured":"Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM. Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis. 2011, 70:2089-94. 10.1136\/ard.2011.153718","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.033","article-title":"Prevalence and associated factors for carriage of Enterobacteriaceae producing ESBLs or carbapenemase and methicillin-resistant Staphylococcus aureus in Hong Kong community","volume":"81","author":"Kwok KO","year":"2020","unstructured":"Kwok KO, Chan E, Chung PH, et al.. Prevalence and associated factors for carriage of Enterobacteriaceae producing ESBLs or carbapenemase and methicillin-resistant Staphylococcus aureus in Hong Kong community. J Infect. 2020, 81:242-7. 10.1016\/j.jinf.2020.05.033","journal-title":"J Infect"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13200","article-title":"Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center","volume":"55","author":"Bharath V","year":"2015","unstructured":"Bharath V, Eckert K, Kang M, Chin-Yee IH, Hsia CC. Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center. Transfusion. 2015, 55:2597-605. 10.1111\/trf.13200","journal-title":"Transfusion"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.11.1185","article-title":"The challenge of drug-induced aseptic meningitis","volume":"159","author":"Moris G","year":"1999","unstructured":"Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med. 1999, 159:1185-94. 10.1001\/archinte.159.11.1185","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-9-28","article-title":"Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease","volume":"9","author":"Kemmotsu Y","year":"2011","unstructured":"Kemmotsu Y, Nakayama T, Matsuura H, Saji T. Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease. Pediatr Rheumatol Online J. 2011, 9:28. 10.1186\/1546-0096-9-28","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13886","article-title":"Aseptic meningitis following therapy with immune globulins: a combination of product features and patient characteristics?","volume":"56","author":"Berg R","year":"2016","unstructured":"Berg R, Fuellenhals E. Aseptic meningitis following therapy with immune globulins: a combination of product features and patient characteristics?. Transfusion. 2016, 56:3021-8. 10.1111\/trf.13886","journal-title":"Transfusion"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921030-00003","article-title":"Adverse effects of intravenous immunoglobulin therapy","volume":"21","author":"Nydegger UE","year":"1999","unstructured":"Nydegger UE, Sturzenegger M. Adverse effects of intravenous immunoglobulin therapy. Drug Saf. 1999, 21:171-85. 10.2165\/00002018-199921030-00003","journal-title":"Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.2918","article-title":"The challenge of drug-induced aseptic meningitis revisited","volume":"174","author":"Mor\u00eds G","year":"2014","unstructured":"Mor\u00eds G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis revisited. JAMA Intern Med. 2014, 174:1511-2. 10.1001\/jamainternmed.2014.2918","journal-title":"JAMA Intern Med"},{"key":"ref13","article-title":"The use of human immunoglobulins--adverse reactions","volume":"29","author":"Pituch-Noworolska A","year":"2010","unstructured":"Pituch-Noworolska A, B\u0142aut-Szl\u00f3sarczyk A, Zwonarz K. The use of human immunoglobulins--adverse reactions. Pol Merkur Lekarski. 2010, 29:202-5.","journal-title":"Pol Merkur Lekarski"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1992.02160170019004","article-title":"Intravenous immune globulin and aseptic meningitis","volume":"146","author":"Rao SP","year":"1992","unstructured":"Rao SP, Teitlebaum J, Miller ST. Intravenous immune globulin and aseptic meningitis. Am J Dis Child. 1992, 146:539-40. 10.1001\/archpedi.1992.02160170019004","journal-title":"Am J Dis Child"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF01701743","article-title":"Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura","volume":"67","author":"Mitterer M","year":"1993","unstructured":"Mitterer M, Pescosta N, Vogetseder W, Mair M, Coser P. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. Ann Hematol. 1993, 67:151-2. 10.1007\/BF01701743","journal-title":"Ann Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010394183","article-title":"Human intravenous immunoglobulin-induced aseptic meningitis: a case report","volume":"52","author":"Chaabane A","year":"2012","unstructured":"Chaabane A, Hamzaoui A, Aouam K, Klai R, Fredj NB, Boughattas NA, Mahjoub S. Human intravenous immunoglobulin-induced aseptic meningitis: a case report. J Clin Pharmacol. 2012, 52:279-81. 10.1177\/0091270010394183","journal-title":"J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.10.980-b","article-title":"Aseptic meningitis associated with high dose intravenous immunoglobulin therapy","volume":"55","author":"Casteels-Van Daele M","year":"1992","unstructured":"Casteels-Van Daele M, Wijndaele L, Brock P, Kruger M, Gillis P. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J Neurol Neurosurg Psychiatry. 1992, 55:980-1. 10.1136\/jnnp.55.10.980-b","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-4-199408150-00004","article-title":"Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors","volume":"121","author":"Sekul EA","year":"1994","unstructured":"Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994, 121:259-62. 10.7326\/0003-4819-121-4-199408150-00004","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1988.03720220017011","article-title":"Administration of immune globulin associated with aseptic meningitis","volume":"259","author":"Kato E","year":"1988","unstructured":"Kato E, Shindo S, Eto Y, Hashimoto N, Yamamoto M, Sakata Y, Hiyoshi Y. Administration of immune globulin associated with aseptic meningitis. JAMA. 1988, 259:3269-71.","journal-title":"JAMA"},{"key":"ref20","article-title":"Intravenous immune globulin and acute aseptic meningitis","volume":"323","author":"Casteels-Van Daele M","year":"1990","unstructured":"Casteels-Van Daele M, Wijndaele L, Hanninck K, Gillis P. Intravenous immune globulin and acute aseptic meningitis. N Engl J Med. 1990, 323:614-5.","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199208000-00019","article-title":"Acute aseptic meningitis associated with administration of intravenous immune globulin","volume":"14","author":"Pallares DE","year":"1992","unstructured":"Pallares DE, Marshall GS. Acute aseptic meningitis associated with administration of intravenous immune globulin. Am J Pediatr Hematol Oncol. 1992, 14:279. 10.1097\/00043426-199208000-00019","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00006565-200212000-00006","article-title":"Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid","volume":"18","author":"Obando I","year":"2002","unstructured":"Obando I, Duran I, Martin-Rosa L, Cano JM, Garcia-Martin FJ. Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid. Pediatr Emerg Care. 2002, 18:429-32. 10.1097\/00006565-200212000-00006","journal-title":"Pediatr Emerg Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199811000-00023","article-title":"Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome","volume":"17","author":"Boyce TG","year":"1998","unstructured":"Boyce TG, Spearman P. Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome. Pediatr Infect Dis J. 1998, 17:1054-6. 10.1097\/00006454-199811000-00023","journal-title":"Pediatr Infect Dis J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/BF01959803","article-title":"Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?","volume":"154","author":"Preminger-Shapiro R","year":"1995","unstructured":"Preminger-Shapiro R, Nussinovitch M, Soen G, Varsano I. Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?. Eur J Pediatr. 1995, 154:866-7. 10.1007\/BF01959803","journal-title":"Eur J Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199210000-00020","article-title":"Cerebrospinal fluid inflammation induced by intravenous immunoglobulins","volume":"11","author":"Kressebuch H","year":"1992","unstructured":"Kressebuch H, Schaad UB, Hirt A, Bianchetti MG. Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. Pediatr Infect Dis J. 1992, 11:894-5. 10.1097\/00006454-199210000-00020","journal-title":"Pediatr Infect Dis J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1745.92858","article-title":"Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency","volume":"6","author":"Kaarthigeyan K","year":"2011","unstructured":"Kaarthigeyan K, Burli VV. Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency. J Pediatr Neurosci. 2011, 6:160-1. 10.4103\/1817-1745.92858","journal-title":"J Pediatr Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omu051","article-title":"Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Jain RS","year":"2014","unstructured":"Jain RS, Kumar S, Aggarwal R, Kookna JC. Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain-Barr\u00e9 syndrome. Oxf Med Case Reports. 2014, 2014:132-4. 10.1093\/omcr\/omu051","journal-title":"Oxf Med Case Reports"},{"key":"ref28","article-title":"Aseptic meningitis induced by intravenous immunoglobulins in a child with acute Epstein-Barr virus infection and thrombocytopenia","volume":"27","author":"Vassalini P","year":"2019","unstructured":"Vassalini P, Ajassa C, Di Ruscio V, et al.. Aseptic meningitis induced by intravenous immunoglobulins in a child with acute Epstein-Barr virus infection and thrombocytopenia. Infez Med. 2019, 27:194-7.","journal-title":"Infez Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(97)70355-x","article-title":"Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G","volume":"130","author":"Kattamis AC","year":"1997","unstructured":"Kattamis AC, Shankar S, Cohen AR. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. J Pediatr. 1997, 130:281-3. 10.1016\/s0022-3476(97)70355-x","journal-title":"J Pediatr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133571","article-title":"Intravenous immunoglobulin-induced aseptic meningitis-a narrative review of the diagnostic process, pathogenesis, preventative measures and treatment","volume":"11","author":"Kretowska-Grunwald A","year":"2022","unstructured":"Kretowska-Grunwald A, Krawczuk-Rybak M, Sawicka-Zukowska M. Intravenous immunoglobulin-induced aseptic meningitis-a narrative review of the diagnostic process, pathogenesis, preventative measures and treatment. J Clin Med. 2022, 11:1-5. 10.3390\/jcm11133571","journal-title":"J Clin Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.09.002","article-title":"Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence","volume":"15","author":"Cherin P","year":"2016","unstructured":"Cherin P, Marie I, Michallet M, et al.. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev. 2016, 15:71-81. 10.1016\/j.autrev.2015.09.002","journal-title":"Autoimmun Rev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2013.05.004","article-title":"Adverse effects of human immunoglobulin therapy","volume":"27","author":"Stiehm ER","year":"2013","unstructured":"Stiehm ER. Adverse effects of human immunoglobulin therapy. Transfus Med Rev. 2013, 27:171-8. 10.1016\/j.tmrv.2013.05.004","journal-title":"Transfus Med Rev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo Y","year":"2018","unstructured":"Guo Y, Tian X, Wang X, Xiao Z. Adverse effects of immunoglobulin therapy. Front Immunol. 2018, 9:1299. 10.3389\/fimmu.2018.01299","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-12-199712150-00020","article-title":"Meningitis and skin reaction after intravenous immune globulin therapy","volume":"127","author":"Gabor EP","year":"1997","unstructured":"Gabor EP. Meningitis and skin reaction after intravenous immune globulin therapy. Ann Intern Med. 1997, 127:1130. 10.7326\/0003-4819-127-12-199712150-00020","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114313-immunoglobulin-induced-aseptic-meningitis-in-juvenile-dermatomyositis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:08Z","timestamp":1707507788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114313-immunoglobulin-induced-aseptic-meningitis-in-juvenile-dermatomyositis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.31808","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,22]]}}}